Umbrella Corporation
Memorandum
Date: April 26 2012
To: All Employees and other Stake holders of Umbrella Corp
From: PhD Kath9876, Lead Scientist for Sector No.13762
Subject: Opening of New Branch with Multiple Experiments to Support our Hypotheses
Our branch has been opened to study the various effects of Nerotonin and Nerotonin II on the effects of our test subjects.
With permission from Mr Wesker and other directors, the branch will be commencing:
1. Our experiments on test subjects namely Kathrine.
2. Research on the mutation rate of Nerotonin with relevance to T-Virus
3. Identification of variants affecting the experiments and removal if necessary
Please view individual research reports and records for more details.
All research complies with Umbrella Corps Ethical Code.
This is a computer generated document and requires no signature.
-1-
